Form D · Other
Envexergy Inc.
New York, NY · CIK 0001736934
Offering snapshot reported Jun 2, 2023 · SEC filing
- Reported sold
- $15.6M Offering amount: $15.6M
- Investors reported
- 13 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 29, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 2, 2023 | Initial | $15,613,243 | No comparison | 13 | SEC filing |
| Jan 25, 2019 | Initial | $3,109,997 | No comparison | 11 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-483221
Source: Form D, filed Jun 2, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Matthew Grierson | Director |
| Michael Jones | Director |
| Perrin Quarshie | Director, Executive |
| David Silverman | Director |
Issuer details
Industry: Other (See others in industry)
Address:
43 West 23 Rd Street 6 Th Floor
New York, NY, 10010
New York, NY, 10010